跳至主要内容
临床试验/ISRCTN32694665
ISRCTN32694665已完成不适用

Intra-articular injection of hyaluronic acid (MW 1500-2000 KDa; HyalOne®) in symptomatic osteoarthritis of the hip: a prospective cohort study

Fidia Farmaceutici S.p.A (Italy)0 个研究点目标入组 304 人开始时间: 2010年5月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
304

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age > 40 years
  • 2. Hip OA with joint pain of at least one year?s duration
  • 2.1. Symptomatic hip OA according to the American College of Rheumatology (ACR)
  • 2.2. Grade I, II, III or IV hip OA according to the Kellgren-Lawrence classification
  • 2.3. Evaluated on an X-ray taken no more than two months before enrolment

排除标准

  • 1. Concomitant use of oral anticoagulant therapy
  • 2. Severe reduction of joint space narrowing evident on X-ray
  • 3. Significant co-morbidities, hypersensitivity to HA or to avian proteins
  • 4. Chronic systemic steroid treatment

研究者

发起方
Fidia Farmaceutici S.p.A (Italy)

相似试验